Integrative analysis of the ST6GALNAC family identifies GATA2-upregulated ST6GALNAC5 as an adverse prognostic biomarker promoting prostate cancer cell invasion. The gene discussed is ST6GALNAC5; the disease is Familial prostate cancer.